Clinical Assessment of a Low-Oestrogen Combined Oral Contraceptive

Abstract

Results of experience with a low-oestrogen combined contraceptive in 1,085 women showed that a dosage of less than 50 μg is compatible with satisfactory cycle control and efficacy. The preparation used in the trial, which contained 0.5 mg dl-norgestrel and 0.03 mg ethinyloestradiol, proved acceptable to most of the women. © 1973, British Medical Journal Publishing Group. All rights reserved.